Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

New therapeutic agents for cancer imparted in recent patents

Sep. 5, 2006

New antibacterial agents disclosed in recent patent literature

Sep. 5, 2006

New antiviral agents disclosed in recent patent literature

Sep. 4, 2006

Recent patents describe novel therapeutic agents for psychosis, depression, sleep disorders, etc.

Sep. 4, 2006

Novel therapeutic agents for nephrotoxicity developed at Hiroshima University

Sep. 4, 2006

Recent GE patent discloses novel diagnostic agents

Sep. 4, 2006

New anxiolytics disclosed in a recent Ono patent

Sep. 1, 2006

sanofi-aventis patents novel cannabinoid CB1 receptor antagonists

Sep. 1, 2006

New strategies for treatment of glaucoma reported in recent patents

Sep. 1, 2006

Novel treatment options for metabolic disorders described in recent patents

Sep. 1, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Atai Therapeutics patents new 5-HT2 receptor agonists
BioWorld Science
Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.